Skip to content
Disclosery

Parkman Healthcare Partners LLC

Follow

13F filer, CIK 1777015, STAMFORD, CT

Parkman Healthcare Partners LLC reported $870,093,347 across 88 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-14. Its ten largest share positions make up 32.42% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001420506-25-002082

Period
2025-06-30
Reported value
$870M
Holdings
88
Top 10 weight
32.42%
New
12
Sold out
15

Largest buys vs the previous quarter

SecurityShares changeApprox. value
IQVnew+109,500$17.3M
WGSnew+175,000$16.2M
DHRadded+46,840$9.25M
DXCMadded+95,508$8.34M
ALNYadded+23,400$7.63M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
BDXexited-120,283-$27.6M
UNHexited-50,213-$26.3M
SYKreduced-27,314-$10.8M
GILDreduced-87,275-$9.68M
THCreduced-44,534-$7.84M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2025

Share positions as resolved from 13F-HR 0001420506-25-002082, largest first. % of portfolio is the value over $864,371,347, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
CVSCVS HEALTH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 180,000 shares; 2025Q1: 496,736 shares; 2025Q2: 517,807 shares 517,807$35.7M4.13%+21,071Timeline
PODDINSULET CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 159,689 shares; 2024Q4: 125,761 shares; 2025Q1: 130,514 shares; 2025Q2: 105,762 shares 105,762$33.2M3.84%-24,752Timeline
BSXBOSTON SCIENTIFIC CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 447,196 shares; 2024Q4: 337,354 shares; 2025Q1: 225,990 shares; 2025Q2: 283,166 shares 283,166$30.4M3.52%+57,176Timeline
ALNYALNYLAM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 25,485 shares; 2024Q4: 38,672 shares; 2025Q1: 68,938 shares; 2025Q2: 92,338 shares 92,338$30.1M3.48%+23,400Timeline
THCTENET HEALTHCARE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 93,753 shares; 2024Q4: 106,987 shares; 2025Q1: 213,418 shares; 2025Q2: 168,884 shares 168,884$29.7M3.44%-44,534Timeline
COOCOOPER COS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 292,593 shares; 2024Q4: 274,569 shares; 2025Q1: 312,650 shares; 2025Q2: 385,479 shares 385,479$27.4M3.17%+72,829Timeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 40,384 shares; 2024Q4: 28,163 shares; 2025Q1: 39,191 shares; 2025Q2: 33,296 shares 33,296$26M3%-5,895Timeline
QIAGEN N.V.QIAGEN N.V.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 359,644 shares; 2025Q2: 498,107 shares 498,107$23.9M2.77%+138,463
ZBHZIMMER BIOMET HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 200,500 shares; 2025Q2: 240,395 shares 240,395$21.9M2.54%+39,895Timeline
DHRDANAHER CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 63,250 shares; 2025Q2: 110,090 shares 110,090$21.7M2.52%+46,840Timeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 129,840 shares; 2024Q4: 115,727 shares; 2025Q1: 168,382 shares; 2025Q2: 166,010 shares 166,010$20.9M2.41%-2,372Timeline
SYKSTRYKER CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 28,000 shares; 2024Q4: 77,717 shares; 2025Q1: 77,690 shares; 2025Q2: 50,376 shares 50,376$19.9M2.31%-27,314Timeline
DXCMDEXCOM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 70,588 shares; 2024Q4: 78,550 shares; 2025Q1: 130,367 shares; 2025Q2: 225,875 shares 225,875$19.7M2.28%+95,508Timeline
EWEDWARDS LIFESCIENCES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 145,214 shares; 2025Q1: 200,819 shares; 2025Q2: 251,741 shares 251,741$19.7M2.28%+50,922Timeline
VERONA PHARMA PLCVERONA PHARMA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 626,452 shares; 2024Q4: 720,657 shares; 2025Q1: 260,421 shares; 2025Q2: 197,898 shares 197,898$18.7M2.17%-62,523
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 425,000 shares; 2024Q4: 1,087,634 shares; 2025Q1: 1,064,506 shares; 2025Q2: 1,298,825 shares 1,298,825$18.2M2.1%+234,319Timeline
IQVIQVIA HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 109,500 shares 109,500$17.3M2%newTimeline
WGSGENEDX HOLDINGS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 175,000 shares 175,000$16.2M1.87%newTimeline
RVTYREVVITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 139,557 shares; 2025Q2: 157,196 shares 157,196$15.2M1.76%+17,639Timeline
GILDGILEAD SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 129,025 shares; 2024Q4: 374,825 shares; 2025Q1: 218,950 shares; 2025Q2: 131,675 shares 131,675$14.6M1.69%-87,275Timeline
KNSAKINIKSA PHARMACEUTICALS INTLQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 755,244 shares; 2024Q4: 765,453 shares; 2025Q1: 762,621 shares; 2025Q2: 488,796 shares 488,796$13.5M1.56%-273,825Timeline
MCKMCKESSON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 23,000 shares; 2025Q1: 22,101 shares; 2025Q2: 17,458 shares 17,458$12.8M1.48%-4,643Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 277,252 shares; 2025Q2: 225,150 shares 225,150$12.4M1.43%-52,102Timeline
TVTXTRAVERE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,086,067 shares; 2024Q4: 1,117,792 shares; 2025Q1: 954,071 shares; 2025Q2: 827,060 shares 827,060$12.2M1.42%-127,011Timeline
SDGRSCHRODINGER INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 559,105 shares; 2024Q4: 563,091 shares; 2025Q1: 481,470 shares; 2025Q2: 587,556 shares 587,556$11.8M1.37%+106,086Timeline
ACLXARCELLX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 66,492 shares; 2024Q4: 44,492 shares; 2025Q1: 67,390 shares; 2025Q2: 174,276 shares 174,276$11.5M1.33%+106,886Timeline
QDELQUIDELORTHO CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 75,000 shares; 2024Q4: 175,415 shares; 2025Q1: 183,678 shares; 2025Q2: 386,646 shares 386,646$11.1M1.29%+202,968Timeline
OMOUTSET MED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 231,099 shares; 2025Q2: 549,052 shares 549,052$10.5M1.22%+317,953Timeline
MBXMBX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 170,000 shares; 2025Q1: 328,323 shares; 2025Q2: 871,933 shares 871,933$9.95M1.15%+543,610Timeline
XERSXERIS BIOPHARMA HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 102,393 shares; 2024Q4: 578,511 shares; 2025Q1: 1,780,454 shares; 2025Q2: 2,107,483 shares 2,107,483$9.84M1.14%+327,029Timeline
NUVLNUVALENT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 23,400 shares; 2024Q4: 23,588 shares; 2025Q1: 109,988 shares; 2025Q2: 119,623 shares 119,623$9.13M1.06%+9,635Timeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 464,048 shares; 2024Q4: 216,881 shares; 2025Q1: 1,000,562 shares; 2025Q2: 1,007,992 shares 1,007,992$9.03M1.04%+7,430Timeline
PTCTPTC THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 195,000 shares; 2024Q4: 177,368 shares; 2025Q1: 280,314 shares; 2025Q2: 181,643 shares 181,643$8.87M1.03%-98,671Timeline
MERUS N VMERUS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 45,349 shares; 2024Q4: 45,680 shares; 2025Q1: 28,230 shares; 2025Q2: 162,980 shares 162,980$8.57M0.99%+134,750
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 657,070 shares; 2024Q4: 381,173 shares; 2025Q1: 425,407 shares; 2025Q2: 647,331 shares 647,331$8.49M0.98%+221,924Timeline
ANIPANI PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 105,000 shares; 2025Q2: 128,478 shares 128,478$8.38M0.97%+23,478Timeline
REPLREPLIMUNE GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 763,747 shares; 2024Q4: 869,759 shares; 2025Q1: 950,399 shares; 2025Q2: 896,710 shares 896,710$8.33M0.96%-53,689Timeline
RXSTRXSIGHT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 184,320 shares; 2024Q4: 300,698 shares; 2025Q1: 631,238 shares; 2025Q2: 633,874 shares 633,874$8.24M0.95%+2,636Timeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 508,283 shares; 2024Q4: 526,973 shares; 2025Q1: 594,987 shares; 2025Q2: 867,813 shares 867,813$8.13M0.94%+272,826Timeline
LIVNLIVANOVA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 101,729 shares; 2024Q4: 174,934 shares; 2025Q1: 166,871 shares; 2025Q2: 175,000 shares 175,000$7.88M0.91%+8,129Timeline
UPBUPSTREAM BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 233,563 shares; 2025Q2: 715,504 shares 715,504$7.86M0.91%+481,941Timeline
KALVKALVISTA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 753,752 shares; 2025Q2: 679,063 shares 679,063$7.68M0.89%-74,689Timeline
DOCSDOXIMITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 93,500 shares; 2025Q2: 120,834 shares 120,834$7.41M0.86%+27,334Timeline
DGXQUEST DIAGNOSTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 55,000 shares; 2024Q4: 90,352 shares; 2025Q1: 62,593 shares; 2025Q2: 40,997 shares 40,997$7.36M0.85%-21,596Timeline
AXGNAXOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 412,888 shares; 2024Q4: 365,703 shares; 2025Q1: 536,832 shares; 2025Q2: 674,551 shares 674,551$7.32M0.85%+137,719Timeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 42,108 shares 42,108$7.27M0.84%newTimeline
ATECALPHATEC HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 396,336 shares; 2024Q4: 228,334 shares; 2025Q1: 446,106 shares; 2025Q2: 648,871 shares 648,871$7.2M0.83%+202,765Timeline
CSTLCASTLE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 296,071 shares; 2024Q4: 304,629 shares; 2025Q1: 350,551 shares; 2025Q2: 352,262 shares 352,262$7.19M0.83%+1,711Timeline
MNKDMANNKIND CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,304,085 shares; 2024Q4: 3,126,727 shares; 2025Q1: 2,493,836 shares; 2025Q2: 1,900,918 shares 1,900,918$7.11M0.82%-592,918Timeline
OPRXOPTIMIZERX CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 475,000 shares; 2025Q2: 507,423 shares 507,423$6.85M0.79%+32,423Timeline
SIBNSI BONE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 185,316 shares; 2024Q4: 216,600 shares; 2025Q1: 231,109 shares; 2025Q2: 362,008 shares 362,008$6.81M0.79%+130,899Timeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 293,928 shares; 2025Q2: 463,601 shares 463,601$6.27M0.73%+169,673Timeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 275,000 shares; 2025Q1: 203,833 shares; 2025Q2: 443,422 shares 443,422$6.18M0.72%+239,589Timeline
AORTARTIVION INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 111,652 shares; 2025Q2: 192,705 shares 192,705$5.99M0.69%+81,053Timeline
VCYTVERACYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 129,260 shares; 2024Q4: 100,301 shares; 2025Q1: 166,278 shares; 2025Q2: 220,387 shares 220,387$5.96M0.69%+54,109Timeline
CERTCERTARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 500,000 shares 500,000$5.85M0.68%newTimeline
WAYWAYSTAR HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 140,000 shares 140,000$5.72M0.66%newTimeline
RAREULTRAGENYX PHARMACEUTICAL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 109,468 shares; 2024Q4: 100,159 shares; 2025Q1: 304,244 shares; 2025Q2: 147,980 shares 147,980$5.38M0.62%-156,264Timeline
INCYINCYTE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 75,000 shares 75,000$5.11M0.59%newTimeline
TMCITREACE MED CONCEPTS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 713,539 shares; 2025Q2: 843,998 shares 843,998$4.96M0.57%+130,459Timeline
RCUSARCUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,025,754 shares; 2024Q4: 1,273,789 shares; 2025Q1: 1,215,629 shares; 2025Q2: 599,610 shares 599,610$4.88M0.56%-616,019Timeline
PERFORMANT HEALTHCARE INCPERFORMANT HEALTHCARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,440,838 shares; 2024Q4: 1,257,805 shares; 2025Q1: 1,060,601 shares; 2025Q2: 1,214,272 shares 1,214,272$4.86M0.56%+153,671
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 191,658 shares; 2024Q4: 193,004 shares; 2025Q1: 174,576 shares; 2025Q2: 150,373 shares 150,373$4.71M0.54%-24,203Timeline
CVRXCVRX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 682,897 shares; 2024Q4: 921,174 shares; 2025Q1: 1,229,522 shares; 2025Q2: 789,099 shares 789,099$4.64M0.54%-440,423Timeline
AMLXAMYLYX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 650,000 shares 650,000$4.17M0.48%newTimeline
FOLDAMICUS THERAPEUTICQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 605,318 shares; 2024Q4: 784,376 shares; 2025Q1: 568,952 shares; 2025Q2: 608,637 shares 608,637$3.49M0.4%+39,685Timeline
QTRXQUANTERIX CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 515,992 shares 515,992$3.43M0.4%newTimeline
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 61,596 shares 61,596$3.4M0.39%newTimeline
DAWNDAY ONE BIOPHARMACEUTICALS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 924,140 shares; 2024Q4: 1,000,474 shares; 2025Q1: 1,043,162 shares; 2025Q2: 500,000 shares 500,000$3.25M0.38%-543,162Timeline
RPIDRAPID MICRO BIOSYSTEMS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 735,621 shares; 2025Q2: 913,443 shares 913,443$3.15M0.36%+177,822Timeline
TERNTERNS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 545,751 shares; 2024Q4: 829,105 shares; 2025Q1: 959,703 shares; 2025Q2: 817,808 shares 817,808$3.05M0.35%-141,895Timeline
NSPRINSPIREMD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 104,081 shares; 2024Q4: 854,716 shares; 2025Q1: 1,171,416 shares; 2025Q2: 1,235,305 shares 1,235,305$2.8M0.32%+63,889Timeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 76,125 shares; 2025Q2: 116,343 shares 116,343$2.74M0.32%+40,218Timeline
DVAXDYNAVAX TECHNOLOGIES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 219,451 shares; 2024Q4: 220,980 shares; 2025Q1: 234,784 shares; 2025Q2: 270,131 shares 270,131$2.68M0.31%+35,347Timeline
NRIXNURIX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 438,971 shares; 2024Q4: 532,172 shares; 2025Q1: 350,420 shares; 2025Q2: 228,271 shares 228,271$2.6M0.3%-122,149Timeline
UTHRUNITED THERAPEUTICS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 64,031 shares; 2024Q4: 37,472 shares; 2025Q1: 10,232 shares; 2025Q2: 8,811 shares 8,811$2.53M0.29%-1,421Timeline
URGNUROGEN PHARMA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 347,541 shares; 2024Q4: 369,861 shares; 2025Q1: 393,153 shares; 2025Q2: 176,702 shares 176,702$2.42M0.28%-216,451Timeline
APGEAPOGEE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 85,000 shares; 2025Q1: 46,663 shares; 2025Q2: 55,404 shares 55,404$2.41M0.28%+8,741Timeline
PGENPRECIGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 3,191,343 shares; 2025Q2: 1,542,823 shares 1,542,823$2.19M0.25%-1,648,520Timeline
CRNXCRINETICS PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 77,623 shares; 2024Q4: 51,133 shares; 2025Q1: 63,940 shares; 2025Q2: 73,412 shares 73,412$2.11M0.24%+9,472Timeline
LUNGPULMONX CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 206,444 shares; 2024Q4: 207,853 shares; 2025Q1: 611,875 shares; 2025Q2: 605,029 shares 605,029$1.57M0.18%-6,846Timeline
ARDXARDELYX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 126,940 shares; 2024Q4: 177,794 shares; 2025Q1: 209,581 shares; 2025Q2: 301,086 shares 301,086$1.18M0.14%+91,505Timeline
ANNXANNEXON INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 328,613 shares; 2024Q4: 330,849 shares; 2025Q1: 351,436 shares; 2025Q2: 404,194 shares 404,194$970K0.11%+52,758Timeline
ATYRATYR PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 150,000 shares 150,000$760K0.09%newTimeline
MASS908 DEVICES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 100,000 shares 100,000$713K0.08%newTimeline
ENTXENTERA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 411,076 shares; 2024Q4: 413,732 shares; 2025Q1: 439,632 shares; 2025Q2: 355,822 shares 355,822$676K0.08%-83,810Timeline
FOCLEDAP TMS S AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 154,832 shares; 2024Q4: 154,832 shares; 2025Q1: 154,832 shares; 2025Q2: 154,832 shares 154,832$255K0.03%0Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
ALKSALKERMES PLC SHSput200,000$5.72Mnew

Sold out in Q2 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
BDXBECTON DICKINSON & CO120,283$27.6Mshares
UNHUNITEDHEALTH GROUP INC50,213$26.3Mshares
RMDRESMED INC22,622$5.06Mshares
GHGUARDANT HEALTH INC89,329$3.81Mshares
PCVXVAXCYTE INC93,431$3.53Mshares
INSMINSMED INC37,901$2.89Mshares
KROSKEROS THERAPEUTICS INC217,753$2.22Mshares
NAMSNEWAMSTERDAM PHARMA COMPANY100,955$2.07Mshares
ICAD INCICAD INC781,670$1.61Mshares
MRVIMARAVAI LIFESCIENCES HLDGS I660,000$1.46Mshares
SLNSILENCE THERAPEUTICS PLC401,746$1.13Mshares
ORICORIC PHARMACEUTICALS INC203,006$1.13Mshares
RLAYRELAY THERAPEUTICS INC188,052$493Kshares
VYNEVYNE THERAPEUTICS INC217,978$344Kshares
IRWDIRONWOOD PHARMACEUTICALS INC205,086$301Kshares

How Q2 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001420506-25-002082 base2025-08-14acceptance time not in the bulk data set